Changeflow GovPing Healthcare & Life Sciences USPTO Patent Application for Capsid Polypeptides
Routine Notice Added Final

USPTO Patent Application for Capsid Polypeptides

Favicon for changeflow.com USPTO Patent Applications - Peptides (C07K)
Published
Detected
Email

Summary

The USPTO has published a new patent application (US20260083863A1) from Dyno Therapeutics, Inc. for capsid polypeptides designed for payload delivery. The application details specific polypeptide sequences and their methods of use in therapeutic applications.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

This document is a publication of a new patent application filed by Dyno Therapeutics, Inc. The application, identified as US20260083863A1, concerns capsid polypeptides, specifically dependoparvovirus capsid polypeptides, intended for use in delivering therapeutic payloads. The filing date was September 26, 2025, with a publication date of March 26, 2026.

This patent application does not impose any new regulatory obligations or compliance requirements on regulated entities. It represents an intellectual property filing rather than a rule, guidance, or enforcement action. Compliance officers in the pharmaceutical and biotechnology sectors should note this filing as it pertains to novel delivery systems, which may impact future product development and competitive landscapes.

Archived snapshot

Mar 26, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

CAPSID POLYPEPTIDES AND METHODS OF USE THEREOF

Application US20260083863A1 Kind: A1 Mar 26, 2026

Assignee

DYNO THERAPEUTICS, INC.

Inventors

Samuel WOLOCK, Stephen MALINA, Demarcus BRIERS

Abstract

The disclosure is directed in part to dependoparvovirus capsid polypeptides that can be used to deliver payloads.

CPC Classifications

A61K 48/0058 A61K 48/0091 C07K 14/005 C12N 15/86 C12N 2750/14122 C12N 2750/14143 C12N 2750/14145 C12N 2750/14152

Filing Date

2025-09-26

Application No.

19342097

View original document →

Named provisions

CAPSID POLYPEPTIDES AND METHODS OF USE THEREOF

Get daily alerts for USPTO Patent Applications - Peptides (C07K)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
March 26th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US20260083863A1

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing 3254.1 Biotechnology
Activity scope
Drug Delivery Systems
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Legal
Topics
Biotechnology Intellectual Property

Get alerts for this source

We'll email you when USPTO Patent Applications - Peptides (C07K) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!